Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Teva Maintains Innocence After DoJ Price Fixing Charge
Consumers Allegedly Overcharged By $350m
Aug 26 2020
•
By
Dean Rudge
Teva has "firmly rejected" the DoJ's allegations • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin